Table 9.
No. | Part of the plant | Extract | Reference | Activity | Reference |
---|---|---|---|---|---|
17 | Leaves Leaves |
EtOH/H2O (19:1) H2O+microwave |
[111] [116,117] |
Inhibition on human immunodeficiency virus type 1 (HIV-1) reverse transcriptase | [112] |
Glucose uptake and gastric emptying | [101,118] | ||||
Inhibition of Glycogen Phosphorylase | [108] | ||||
18 | Stems | N. a. | [95] | Haemolytic Activity | [99] |
Obtained by synthesis | [99] | ||||
19 | Leaves | EtOH | [89] | Prevention or treatment of disorders related to high blood sugar, high blood lipids, or blood | [115] |
20 | Leaves | N. a. | [108] | Glucose uptake and gastric emptying | [101,118] |
Haemolytic Activity | [51] | ||||
Inhibition of Glycogen Phosphorylase | [103] | ||||
Antimicrobial Activities | [119] | ||||
21 | Leaves | N. a. | [108] | Inhibition of the growth of HL60, A549 and | [105] [119] |
Leaves | EtOH/H2O (3:2) | [105] | DU145 cancer cells | ||
Leaves | MeOH/CH2Cl2 (1:1) | [104] | Amylase activity, total protein content and seedling growth | ||
22 | Leaves | EtOH | [89] | Prevention or treatment of disorders related to high blood sugar, high blood lipids, or blood | [115] |
23 | Leaves | EtOH | [89] | Prevention or treatment of disorders related to high blood sugar, high blood lipids, or blood | [115] |
24 | Leaves | EtOH | [89] | Prevention or treatment of disorders related to high blood sugar, high blood lipids, or blood | [115] |
25 | Stems | N. a. | [95] | - | - |
N. a. = Not available